"From a health benefit standpoint, specifically, the employees have to be able to access care, they have to be able to afford the care that they are going to receive, and the benefits also have to be relevant to employees," Bruce Sherman, MD explains.
In a discussion about health equity in the US, Bruce Sherman, MD, medical director, North Carolina Business Coalition on Health, and adjunct professor, Department of Public Health Education, University of North Carolina-Greensboro, addressed the importance of equitable health benefit design.
Transcript
Equitable health benefit design is central to addressing health inequities in the US, according to your article. Can you elaborate on the significance of equitable benefits in the context of health care access and outcomes?
Certainly, and thanks for the opportunity to respond to your questions. From the standpoint of equitable benefits broadly, these include access to affordable and accessible health care, as well as stable work, a living wage, and opportunity for professional or career advancement. But from a health benefit standpoint, specifically, the employees have to be able to access care, they have to be able to afford the care that they are going to receive, and the benefits also have to be relevant to employees.
So we've seen a great deal of interest and recognition of the fact that unmet social needs are a priority for many employees where they may actually put greater focus on those concerns than their physical health because of personal priority. So employers need to understand: What do employees need? So it's not just accessibility and affordability, but it's also relevant to the employees.
The other critical component relates to relationship-centered care and the fact that there is so much medical mistrust, implicit bias, systemic factors that negatively impact individuals, particularly in minority subpopulations, in lower income subgroups, that we are only going to see improvements in health outcomes and a narrowing of the health inequity gap if individuals can have a meaningful and trusted relationship with their clinician because that's what will help to overcome medical mistrust and implicit bias. And when that takes place, that's when we will see outcomes improve.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Medicaid, Medicare Policy Changes Could Lead to More Than 25,000 Additional Deaths, Study Says
April 30th 2024Researchers also estimated that more than 700,000 Americans with diabetes could lose insurance coverage if these proposed retractions are put into place, with some new policies already in effect.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More